These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15585409)
1. Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus. Wong LF; Ralph GS; Walmsley LE; Bienemann AS; Parham S; Kingsman SM; Uney JB; Mazarakis ND Mol Ther; 2005 Jan; 11(1):89-95. PubMed ID: 15585409 [TBL] [Abstract][Full Text] [Related]
2. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Dowd E; Monville C; Torres EM; Wong LF; Azzouz M; Mazarakis ND; Dunnett SB Eur J Neurosci; 2005 Nov; 22(10):2587-95. PubMed ID: 16307601 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 requires glial-cell-line-derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons. Lenhard T; Schober A; Suter-Crazzolara C; Unsicker K Mol Cell Neurosci; 2002 Jun; 20(2):181-97. PubMed ID: 12093153 [TBL] [Abstract][Full Text] [Related]
4. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. Hottinger AF; Azzouz M; Déglon N; Aebischer P; Zurn AD J Neurosci; 2000 Aug; 20(15):5587-93. PubMed ID: 10908595 [TBL] [Abstract][Full Text] [Related]
5. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702. Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector. Azzouz M; Ralph S; Wong LF; Day D; Askham Z; Barber RD; Mitrophanous KA; Kingsman SM; Mazarakis ND Neuroreport; 2004 Apr; 15(6):985-90. PubMed ID: 15076720 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Kelly S; Zhang ZJ; Zhao H; Xu L; Giffard RG; Sapolsky RM; Yenari MA; Steinberg GK Ann Neurol; 2002 Aug; 52(2):160-7. PubMed ID: 12210785 [TBL] [Abstract][Full Text] [Related]
8. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Pérez-Navarro E; Arenas E; Marco S; Alberch J Eur J Neurosci; 1999 Jan; 11(1):241-9. PubMed ID: 9987028 [TBL] [Abstract][Full Text] [Related]
9. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Semkova I; Schilling M; Henrich-Noack P; Rami A; Krieglstein J Brain Res; 1996 Apr; 717(1-2):44-54. PubMed ID: 8738252 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438 [TBL] [Abstract][Full Text] [Related]
11. GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. Boscia F; Esposito CL; Di Crisci A; de Franciscis V; Annunziato L; Cerchia L PLoS One; 2009 Aug; 4(8):e6486. PubMed ID: 19649251 [TBL] [Abstract][Full Text] [Related]
12. Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. Bemelmans AP; Husson I; Jaquet M; Mallet J; Kosofsky BE; Gressens P J Neurosci Res; 2006 Jan; 83(1):50-60. PubMed ID: 16299771 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. Nicole O; Ali C; Docagne F; Plawinski L; MacKenzie ET; Vivien D; Buisson A J Neurosci; 2001 May; 21(9):3024-33. PubMed ID: 11312287 [TBL] [Abstract][Full Text] [Related]
14. Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease. Lo Bianco C; Déglon N; Pralong W; Aebischer P Neurobiol Dis; 2004 Nov; 17(2):283-9. PubMed ID: 15474365 [TBL] [Abstract][Full Text] [Related]
15. GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose deprived hippocampal slice cultures: a possible effect of glutamate transporter up-regulation. Bonde C; Sarup A; Schousboe A; Gegelashvili G; Noraberg J; Zimmer J Neurochem Int; 2003; 43(4-5):381-8. PubMed ID: 12742082 [TBL] [Abstract][Full Text] [Related]
16. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Georgievska B; Jakobsson J; Persson E; Ericson C; Kirik D; Lundberg C Hum Gene Ther; 2004 Oct; 15(10):934-44. PubMed ID: 15585109 [TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. Natsume A; Mata M; Wolfe D; Oligino T; Goss J; Huang S; Glorioso J; Fink DJ J Neurotrauma; 2002 Jan; 19(1):61-8. PubMed ID: 11852979 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus. Yoo YM; Lee CJ; Lee U; Kim YJ Exp Neurol; 2006 Aug; 200(2):407-17. PubMed ID: 16690057 [TBL] [Abstract][Full Text] [Related]
19. HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Harvey BK; Chang CF; Chiang YH; Bowers WJ; Morales M; Hoffer BJ; Wang Y; Federoff HJ Exp Neurol; 2003 Sep; 183(1):47-55. PubMed ID: 12957487 [TBL] [Abstract][Full Text] [Related]
20. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]